Business description: Assertio Holdings

Number of employees: 53
Sales by Activity: Assertio Holdings
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Pharmaceuticals | 111M | 156M | 152M | 125M | 119M |
Geographical breakdown of sales: Assertio Holdings
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 111M | 156M | 152M | 125M | 119M |
Executive Committee: Assertio Holdings
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Reisenauer
CEO | Chief Executive Officer | 61 | 2025-09-30 |
Composition of the Board of Directors: Assertio Holdings
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 2026-06-15 |
Punit Patel
BRD | Director/Board Member | - | 2026-06-15 |
Company details: Assertio Holdings

Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | +3.13% | +54.78% | +125.16% | 1,135B | ||
| +0.94% | +4.93% | +39.94% | +78.72% | 635B | ||
| +0.39% | +1.44% | +25.75% | +97.48% | 505B | ||
| +1.43% | +4.56% | +46.20% | +66.91% | 378B | ||
| -3.21% | -2.10% | +59.78% | +33.22% | 358B | ||
| -0.41% | +2.23% | +22.48% | +48.54% | 295B | ||
| +0.23% | +3.28% | +2.57% | +21.89% | 266B | ||
| +1.22% | +4.63% | +52.71% | +64.85% | 237B | ||
| +1.70% | +3.67% | +31.73% | +102.15% | 193B | ||
| Average | +0.27% | +1.60% | +37.33% | +70.99% | 444.85B | |
| Weighted average by Cap. | +0.29% | +1.63% | +41.32% | +83.37% |

















